1. Prevention of Central Line-Associated Bloodstream Infections in Children: Current Challenges and Opportunities
- Author
-
Elizabeth H. Mack and Allison Whalen
- Subjects
Central line ,medicine.medical_specialty ,business.industry ,Maternal and child health ,Morbidity risk ,Adjunct ,law.invention ,Indirect costs ,Randomized controlled trial ,law ,Bloodstream infection ,Expert opinion ,Pediatrics, Perinatology and Child Health ,Medicine ,business ,Intensive care medicine - Abstract
No longer are healthcare-acquired conditions considered expected costs of care. Given the lack of randomized controlled trials in children, often we are left with extrapolating from adult literature, recommended prevention bundles, and expert opinion. Additionally, strategies that are considered adjunct to the standard prevention bundles have been examined. Here, we review standard central line-associated bloodstream infection (CLABSI) prevention bundles as well as adjunct prevention strategies. Due to the mortality and morbidity risk, indirect and direct costs, and the inevitable penalties associated with these largely preventable harms, we must reliably implement bundles to avoid these healthcare-acquired infections.
- Published
- 2020